Epic Sciences
Executives
9Board of Directors
1Epic Sciences Board of Director
1 Board of directors
Epic Sciences has 1 board of directors, including Murali Prahalad.
Name | Firm | Work History | Other Seats |
|---|---|---|---|
Murali Prahalad | Dr. Prahalad brings over eighteen years of executive and entrepreneurial experience in the life sciences industry. Prior to joining Iridia, he served as President and CEO of Epic Sciences, Inc. (EPIC), a venture backed company that builds predictive, blood-based tests of drug response in cancer. While at Epic, Dr. Prahalad helped advance the company’s functional cell profiling technology platform, develop, launch and obtain Medicare reimbursement for its leading test in metastatic prostate cancer and raise over $128M in venture financing. Prior to Epic, Dr. Prahalad also held various roles at Life Technologies Corporation, a global leader in reagents and instruments for biomedical research. His final role at Life Technologies was VP, Corporate Strategy which culminated in the strategic sale of Life Technologies to ThermoFisher Scientific (NYSE: TMO) in 2013 for $15.5B – the largest non-pharmaceutical acquisition in the biotechnology space. Prior to Life Technologies, Dr. Prahalad was VP of Business Development for Sequenom, Inc., a pioneer in blood-based, pre-natal diagnostics. Dr. Prahalad received his B.Sc. with Honors from the University of Michigan and Doctorate in Biochemistry & Molecular Pharmacology from Harvard University. | Epic Sciences |
Name | Murali Prahalad |
|---|---|
Firm | |
Work History | Dr. Prahalad brings over eighteen years of executive and entrepreneurial experience in the life sciences industry. Prior to joining Iridia, he served as President and CEO of Epic Sciences, Inc. (EPIC), a venture backed company that builds predictive, blood-based tests of drug response in cancer. While at Epic, Dr. Prahalad helped advance the company’s functional cell profiling technology platform, develop, launch and obtain Medicare reimbursement for its leading test in metastatic prostate cancer and raise over $128M in venture financing. Prior to Epic, Dr. Prahalad also held various roles at Life Technologies Corporation, a global leader in reagents and instruments for biomedical research. His final role at Life Technologies was VP, Corporate Strategy which culminated in the strategic sale of Life Technologies to ThermoFisher Scientific (NYSE: TMO) in 2013 for $15.5B – the largest non-pharmaceutical acquisition in the biotechnology space. Prior to Life Technologies, Dr. Prahalad was VP of Business Development for Sequenom, Inc., a pioneer in blood-based, pre-natal diagnostics. Dr. Prahalad received his B.Sc. with Honors from the University of Michigan and Doctorate in Biochemistry & Molecular Pharmacology from Harvard University. |
Other Seats | Epic Sciences |
Epic Sciences Management Team
9 Team Members
Epic Sciences has 9 executives. Epic Sciences's founder is Dena Marrinucci. Epic Sciences's current Chief Medical Officer is Richard Wenstrup M D.
Name | Work History | Title | Status |
|---|---|---|---|
Dena Marrinucci | Founder | Current | |
Richard Wenstrup M D | Oxford Immunotec, Myriad Genetics, and University of Cincinnati | Chief Medical Officer | Current |
David Nelson | Provista Diagnostics, Santech, and Acidophil | Founder, Chief Executive Officer, President | Former |
Murali K Prahalad | Chief Executive Officer, President | Former | |
Michael R Rodriguez | Tickets.com, and Edix | Chief Financial Officer | Former |
Name | Dena Marrinucci | Richard Wenstrup M D | David Nelson | Murali K Prahalad | Michael R Rodriguez |
|---|---|---|---|---|---|
Work History | Oxford Immunotec, Myriad Genetics, and University of Cincinnati | Provista Diagnostics, Santech, and Acidophil | Tickets.com, and Edix | ||
Title | Founder | Chief Medical Officer | Founder, Chief Executive Officer, President | Chief Executive Officer, President | Chief Financial Officer |
Status | Current | Current | Former | Former | Former |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.